ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,717, issued on July 21, was assigned to Washington University (St. Louis) and Senseion Therapeutics Inc. (St. Louis).
"Suppression of inflammasome activation" was invented by Rajan Sah (St. Louis), Hongzhen Hu (St. Louis), Ashutosh Kumar (St. Louis) and Daniel Lerner (St. Louis).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to various methods of suppressing inflammasome activation. For example, the present invention relates to various methods of treating a disease or condition in which inflammation contributes to the disease or condition state."
The patent was filed on Jan. 11, 2021, under Application No. 17/791,71...